Molecular Profiling and Targeted Therapies in Gliomas

被引：3

作者：

Felistia, Yuli ^{[1
]}

Wen, Patrick Y. ^{[2
,3
]}

机构：

[1] Natl Brain Ctr Hosp, Neurooncol Div, Jakarta, Indonesia

[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Ctr Neurooncol,Div Neurooncol, Dept Neurol, 450 Brookline Ave, Boston, MA 02215 USA

[3] Harvard Med Sch, 450 Brookline Ave, Boston, MA 02215 USA

来源：

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS | 2023年 / 23卷 / 10期

关键词：

Molecular profiling; Targeted therapy; Glioma; Glioblastoma; CENTRAL-NERVOUS-SYSTEM; DABRAFENIB PLUS TRAMETINIB; METASTATIC BREAST-CANCER; GRADE GLIOMA; PHASE-II; INHIBITOR; RECURRENT; TUMORS; CLASSIFICATION; CRIZOTINIB;

D O I：

10.1007/s11910-023-01299-7

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Purpose of ReviewMolecular profiling enables the evaluation of genetic alterations for the diagnosis and classification of gliomas and the selection of appropriate therapies. This review summarizes the current role of molecular profiling and targeted therapies for gliomas.Recent FindingsMolecular profiling is an integral part of the 2021 WHO classification of gliomas. Progress in the development of targeted therapies remains limited due to many factors including the presence of the blood-brain barrier and issues of tumor heterogeneity. Nonetheless, advances have been made with the IDH1/2 inhibitor vorasidenib for IDH-mutant grade 2 gliomas, the combination of dabrafenib and trametinib for BRAFV600E mutated gliomas, and the therapies for subsets of patients with fusions and H3K27M-altered diffuse midline gliomas.SummaryWhile there has been progress in the use of molecular profiling for the classification and treatment of gliomas, much work remains for targeted therapies to realize their potential.

引用

页码：627 / 636

页数：10

共 92 条

[11] Bouffet E, 2022, J CLIN ONCOL, V40
[12] The Somatic Genomic Landscape of Glioblastoma
Brennan, Cameron W.
Verhaak, Roel G. W.
McKenna, Aaron
Campos, Benito
Noushmehr, Houtan
Salama, Sofie R.
Zheng, Siyuan
Chakravarty, Debyani
Sanborn, J. Zachary
Berman, Samuel H.
Beroukhim, Rameen
Bernard, Brady
Wu, Chang-Jiun
Genovese, Giannicola
Shmulevich, Ilya
Barnholtz-Sloan, Jill
Zou, Lihua
Vegesna, Rahulsimham
Shukla, Sachet A.
Ciriello, Giovanni
Yung, W. K.
Zhang, Wei
Sougnez, Carrie
Mikkelsen, Tom
Aldape, Kenneth
Bigner, Darell D.
Van Meir, Erwin G.
Prados, Michael
Sloan, Andrew
Black, Keith L.
Eschbacher, Jennifer
Finocchiaro, Gaetano
Friedman, William
Andrews, David W.
Guha, Abhijit
Iacocca, Mary
O'Neill, Brian P.
Foltz, Greg
Myers, Jerome
Weisenberger, Daniel J.
Penny, Robert
Kucherlapati, Raju
Perou, Charles M.
Hayes, D. Neil
Gibbs, Richard
Marra, Marco
Mills, Gordon B.
Lander, Eric
Spellman, Paul
Wilson, Richard
[J]. CELL, 2013, 155 (02) : 462 - 477
[13] DNA methylation-based classification of central nervous system tumours
Capper, David
Jones, David T. W.
Sill, Martin
Hovestadt, Volker
Schrimpf, Daniel
Sturm, Dominik
Koelsche, Christian
Sahm, Felix
Chavez, Lukas
Reuss, David E.
Kratz, Annekathrin
Wefers, Annika K.
Huang, Kristin
Pajtler, Kristian W.
Schweizer, Leonille
Stichel, Damian
Olar, Adriana
Engel, Nils W.
Lindenberg, Kerstin
Harter, Patrick N.
Braczynski, Anne K.
Plate, Karl H.
Dohmen, Hildegard
Garvalov, Boyan K.
Coras, Roland
Hoelsken, Annett
Hewer, Ekkehard
Bewerunge-Hudler, Melanie
Schick, Matthias
Fischer, Roger
Beschorner, Rudi
Schittenhelm, Jens
Staszewski, Ori
Wani, Khalida
Varlet, Pascale
Pages, Melanie
Temming, Petra
Lohmann, Dietmar
Selt, Florian
Witt, Hendrik
Milde, Till
Witt, Olaf
Aronica, Eleonora
Giangaspero, Felice
Rushing, Elisabeth
Scheurlen, Wolfram
Geisenberger, Christoph
Rodriguez, Fausto J.
Becker, Albert
Preusser, Matthias
[J]. NATURE, 2018, 555 (7697) : 469 - +
[14] Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Ceccarelli, Michele
Barthel, Floris P.
Malta, Tathiane M.
Sabedot, Thais S.
Salama, Sofie R.
Murray, Bradley A.
Morozova, Olena
Newton, Yulia
Radenbaugh, Amie
Pagnotta, Stefano M.
Anjum, Samreen
Wang, Jiguang
Manyam, Ganiraju
Zoppoli, Pietro
Ling, Shiyun
Rao, Arjun A.
Grifford, Mia
Cherniack, Andrew D.
Zhang, Hailei
Poisson, Laila
Carlotti, Carlos Gilberto, Jr.
Tirapelli, Daniela Pretti da Cunha
Rao, Arvind
Mikkelsen, Tom
Lau, Ching C.
Yung, W. K. Alfred
Rabadan, Raul
Huse, Jason
Brat, Daniel J.
Lehman, Norman L.
Barnholtz-Sloan, Jill S.
Zheng, Siyuan
Hess, Kenneth
Rao, Ganesh
Meyerson, Matthew
Beroukhim, Rameen
Cooper, Lee
Akbani, Rehan
Wrensch, Margaret
Haussler, David
Aldape, Kenneth D.
Laird, Peter W.
Gutmann, David H.
Noushmehr, Houtan
Iavarone, Antonio
Verhaak, Roel G. W.
[J]. CELL, 2016, 164 (03) : 550 - 563
[15] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Chapman, Paul B.
Hauschild, Axel
Robert, Caroline
Haanen, John B.
Ascierto, Paolo
Larkin, James
Dummer, Reinhard
Garbe, Claus
Testori, Alessandro
Maio, Michele
Hogg, David
Lorigan, Paul
Lebbe, Celeste
Jouary, Thomas
Schadendorf, Dirk
Ribas, Antoni
O'Day, Steven J.
Sosman, Jeffrey A.
Kirkwood, John M.
Eggermont, Alexander M. M.
Dreno, Brigitte
Nolop, Keith
Li, Jiang
Nelson, Betty
Hou, Jeannie
Lee, Richard J.
Flaherty, Keith T.
McArthur, Grant A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) : 2507 - 2516
[16] Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma
Chi, Andrew S.
Cahill, Daniel P.
Reardon, David A.
Wen, Patrick Y.
Mikkelsen, Tom
Peereboom, David M.
Wong, Eric T.
Gerstner, Elizabeth R.
Dietrich, Jorg
Plotkin, Scott R.
Norden, Andrew D.
Lee, Eudocia Q.
Nayak, Lakshmi
Tanaka, Shota
Wakimoto, Hiroaki
Lelic, Nina
Koerner, Mara V.
Klofas, Lindsay K.
Bertalan, Mia S.
Arrillaga-Romany, Isabel C.
Betensky, Rebecca A.
Curry, William T.
Borger, Darrel R.
Balaj, Leonora
Kitchen, Robert R.
Chakrabortty, Sudipto K.
Valentino, Michael D.
Skog, Johan
Breakefield, Xandra O.
Iafrate, A. John
Batchelor, Tracy T.
[J]. JCO PRECISION ONCOLOGY, 2020, 4 : 593 - 613
[17] Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
de la Fuente, Macarena, I
Colman, Howard
Rosenthal, Mark
Van Tine, Brian A.
Levacic, Danijela
Walbert, Tobias
Gan, Hui K.
Vieito, Maria
Milhem, Mohammed M.
Lipford, Kathryn
Forsyth, Sanjeev
Guichard, Sylvie M.
Mikhailov, Yelena
Sedkov, Alexander
Brevard, Julie
Kelly, Patrick F.
Mohamed, Hesham
Monga, Varun
[J]. NEURO-ONCOLOGY, 2023, 25 (01) : 146 - 156
[18] Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Doebele, Robert C.
Drilon, Alexander
Paz-Ares, Luis
Siena, Salvatore
Shaw, Alice T.
Farago, Anna F.
Blakely, Collin M.
Seto, Takashi
Cho, Byung Chul
Tosi, Diego
Besse, Benjamin
Chawla, Sant P.
Bazhenova, Lyudmila
Krauss, John C.
Chae, Young Kwang
Barve, Minal
Garrido-Laguna, Ignacio
Liu, Stephen V.
Conkling, Paul
John, Thomas
Fakih, Marwan
Sigal, Darren
Loong, Herbert H.
Buchschacher, Gary L., Jr.
Garrido, Pilar
Nieva, Jorge
Steuer, Conor
Overbeck, Tobias R.
Bowles, Daniel W.
Fox, Elizabeth
Riehl, Todd
Chow-Maneval, Edna
Simmons, Brian
Cui, Na
Johnson, Ann
Eng, Susan
Wilson, Timothy R.
Demetri, George D.
[J]. LANCET ONCOLOGY, 2020, 21 (02) : 271 - 282
[19] Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
Doz, Francois
van Tilburg, Cornelis M.
Geoerger, Birgit
Hojgaard, Martin
Ora, Ingrid
Boni, Valentina
Capra, Michael
Chisholm, Julia
Chung, Hyun Cheol
DuBois, Steven G.
Gallego-Melcon, Soledad
Gerber, Nicolas U.
Goto, Hiroaki
Grilley-Olson, Juneko E.
Hansford, Jordan R.
Hong, David S.
Italiano, Antoine
Kang, Hyoung Jin
Nysom, Karsten
Thorwarth, Anne
Stefanowicz, Joanna
Tahara, Makoto
Ziegler, David S.
Gavrilovic, Igor T.
Norenberg, Ricarda
Dima, Laura
De la Cuesta, Esther
Laetsch, Theodore W.
Drilon, Alexander
Perreault, Sebastien
[J]. NEURO-ONCOLOGY, 2022, 24 (06) : 997 - 1007
[20] Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study
Draaisma, Kaspar
Chatzipli, Aikaterini
Taphoorn, Martin
Kerkhof, Melissa
Weyerbrock, Astrid
Sanson, Marc
Hoeben, Ann
Lukacova, Slavka
Lombardi, Giuseppe
Leenstra, Sieger
Hanse, Monique
Fleischeuer, Ruth
Watts, Colin
McAbee, Joseph
Angelopoulos, Nicos
Gorlia, Thierry
Golfinopoulos, Vassilis
Kros, Johan M.
Verhaak, Roel G. W.
Bours, Vincent
van den Bent, Martin J.
McDermott, Ultan
Robe, Pierre A.
French, Pim J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (01) : 81 - +

← 1 2 3 4 5 6 7 8 9 10 →